Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

<h4>Background</h4>There is currently no consensus regarding the optimal number of chemotherapy cycles to be administered before and after interval debulking surgery (IDS) in patients with advanced ovarian cancer. This study aimed to evaluate the impact of the number of neoadjuvant chemo...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Young Shin Chung, Yun-Ji Kim, Inha Lee, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183754&type=printable